Benign Prostatic Hyperplasia
3 competing products in clinical development for Benign Prostatic Hyperplasia.
Pipeline by Phase
Phase 32
Approved1
All Products (3)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Tadalafil + Placebo + Alpha1 Blocker | Eli Lilly | Approved | Completed | 85 |
| Tadalafil + Placebo | Eli Lilly | Phase 3 | Completed | 77 |
| Placebo + tadalafil | Eli Lilly | Phase 3 | Completed | 77 |